Kurtis J. Haro, Ph.D. - Related publications

2012 Weill Cornell Medical College, New York, NY, United States 
Pharmacology, Radiation Physics
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Zaitoua AJ, Kaur A, Raghavan M. Variations in MHC class I antigen presentation and immunopeptidome selection pathways. F1000research. 9. PMID 33014341 DOI: 10.12688/f1000research.26935.1   
2020 Marino F, Semilietof A, Michaux J, Pak HS, Coukos G, Müller M, Bassani-Sternberg M. Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference. Frontiers in Immunology. 11: 1981. PMID 32983136 DOI: 10.3389/fimmu.2020.01981   
2020 Stryhn A, Kongsgaard M, Rasmussen M, Harndahl MN, Østerbye T, Bassi MR, Thybo S, Gabriel M, Hansen MB, Nielsen M, Christensen JP, Randrup Thomsen A, Buus S. A Systematic, Unbiased Mapping of CD8 and CD4 T Cell Epitopes in Yellow Fever Vaccinees. Frontiers in Immunology. 11: 1836. PMID 32983097 DOI: 10.3389/fimmu.2020.01836   
2020 Gutierrez-Hoffmann MG, O'Meally RN, Cole RN, Tiniakou E, Darrah E, Soloski MJ. -Induced Changes in the Class II Self-Immunopeptidome Displayed on HLA-DR Molecules Expressed by Dendritic Cells. Frontiers in Medicine. 7: 568. PMID 33043033 DOI: 10.3389/fmed.2020.00568   
2020 Xie X, Hu Y, Ye T, Chen Y, Zhou L, Li F, Xi X, Wang S, He Y, Gao X, Wei W, Ma G, Li Y. Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nature Biomedical Engineering. PMID 33046865 DOI: 10.1038/s41551-020-00624-6   
2020 Singh NK, Alonso JA, Harris DT, Anderson SD, Ma J, Hellman LM, Rosenberg AM, Kolawole EM, Evavold BD, Kranz DM, Baker BM. An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes. Biochemistry. PMID 33074657 DOI: 10.1021/acs.biochem.0c00689   
2020 Ting TA, Chaumet A, Bard FA. Targeting c-Myc with a novel Peptide Nuclear Delivery Device. Scientific Reports. 10: 17762. PMID 33082422 DOI: 10.1038/s41598-020-73998-x   
2020 Ortega PA, Silva-Miranda M, Torres-Larios A, Campos-Chávez E, Franken KCLCM, Ottenhoff THM, Ivanyi J, Espitia C. Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen. Frontiers in Immunology. 11: 577815. PMID 33117380 DOI: 10.3389/fimmu.2020.577815   
2020 Huang GL, Nampe DP, Yi J, Gabrelow GB, Negri KR, Kamb A, Xu H. A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitro. Plos One. 15: e0241421. PMID 33166305 DOI: 10.1371/journal.pone.0241421   
2020 Walter F, Winter E, Rahn S, Heidland J, Meier S, Struzek AM, Lettau M, Philipp LM, Beckinger S, Otto L, Möller JL, Helm O, Wesch D, Scherließ R, Sebens S. Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses. Plos One. 15: e0239369. PMID 32997691 DOI: 10.1371/journal.pone.0239369   
2020 Becher LRE, Nevala WK, Sutor SL, Abergel M, Hoffmann MM, Parks CA, Pease LR, Schrum AG, Markovic SN, Gil D. Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation. Blood Advances. 4: 5343-5356. PMID 33125463 DOI: 10.1182/bloodadvances.2020002255   
2020 Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, Carbajo D, Abel B, Newell EW, Bettinotti MP, Benner SE, Patel EU, Littlefield K, Laeyendecker O, Shoham S, et al. CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation. Biorxiv : the Preprint Server For Biology. PMID 33052343 DOI: 10.1101/2020.10.08.330688   
2020 Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nature Immunology. PMID 32999467 DOI: 10.1038/s41590-020-00808-x   
2020 Didonna A, Damotte V, Shams H, Matsunaga A, Caillier SJ, Dandekar R, Misra MK, Mofrad MRK, Oksenberg JR, Hollenbach JA. A splice acceptor variant in HLA-DRA affects the conformation and cellular localization of the class II DR alpha-chain. Immunology. PMID 32986852 DOI: 10.1111/imm.13273   
2020 Sidney J, Peters B, Sette A. Epitope prediction and identification- adaptive T cell responses in humans. Seminars in Immunology. 101418. PMID 33131981 DOI: 10.1016/j.smim.2020.101418   
2020 Chauhan P, Hu S, Prasad S, Sheng WS, Lokensgard JR. Programmed death ligand-1 induction restrains the cytotoxic T lymphocyte response against microglia. Glia. PMID 33128485 DOI: 10.1002/glia.23932   
2020 Dolasia K, Nazar F, Mukhopadhyay S. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice. European Journal of Immunology. PMID 33084017 DOI: 10.1002/eji.201848071   
2020 Wang J, Jelcic I, Mühlenbruch L, Haunerdinger V, Toussaint NC, Zhao Y, Cruciani C, Faigle W, Naghavian R, Foege M, Binder TMC, Eiermann T, Opitz L, Fuentes-Font L, Reynolds R, et al. HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis. Cell. PMID 33091337 DOI: 10.1016/j.cell.2020.09.054   
2020 El Bissati K, Zhou Y, Paulillo SM, Raman SK, Karch CP, Reed S, Estes A, Estes A, Lykins J, Burkhard P, McLeod R. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Scientific Reports. 10: 16984. PMID 33046728 DOI: 10.1038/s41598-020-73210-0   
2020 Yuan H, Ma L, Zhang L, Li X, Xia C. Crystal structure of the giant panda MHC class I complex: first insights into the viral peptide presentation profile in the bear family. Protein Science : a Publication of the Protein Society. PMID 33078460 DOI: 10.1002/pro.3980   
2020 Wang J, Urbanska K, Sharma P, Nejati R, Shaw L, Lim MS, Schuster SJ, Jr DJP. A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families. Vaccines. 8. PMID 33142718 DOI: 10.3390/vaccines8040631   
2020 Luo YL, Liang LF, Gan YJ, Liu J, Zhang Y, Fan YN, Zhao G, Czarna A, Lu ZD, Du XJ, Shen S, Xu CF, Lian ZX, Wang J. An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance. Acs Applied Materials & Interfaces. PMID 33070614 DOI: 10.1021/acsami.0c10885   
2020 Song L, Bretz AC, Gravemeyer J, Spassova I, Muminova S, Gambichler T, Sriram A, Ferrone S, Becker JC. The HDAC Inhibitor Domatinostat Promotes Cell Cycle Arrest, Induces Apoptosis and Increases Immunogenicity of Merkel Cell Carcinoma Cells. The Journal of Investigative Dermatology. PMID 33002502 DOI: 10.1016/j.jid.2020.08.023   
2020 Lee J, Sheen JH, Lim O, Lee Y, Ryu J, Shin D, Kim YY, Kim M. Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy. Scientific Reports. 10: 17753. PMID 33082438 DOI: 10.1038/s41598-020-74772-9   
2020 Ding ZC, Shi H, Aboelella NS, Fesenkova K, Park EJ, Liu Z, Pei L, Li J, McIndoe RA, Xu H, Piazza GA, Blazar BR, Munn DH, Zhou G. Persistent STAT5 activation reprograms the epigenetic landscape in CD4 T cells to drive polyfunctionality and antitumor immunity. Science Immunology. 5. PMID 33127608 DOI: 10.1126/sciimmunol.aba5962   
2020 Hu G, Miao Y, Luo X, Chu W, Fu Y. Identification of a novel cell-penetrating peptide derived from the capsid protein of chicken anemia virus and its application in gene delivery. Applied Microbiology and Biotechnology. PMID 33141296 DOI: 10.1007/s00253-020-10988-z   
2020 Kürten CHL, Deuß E, Lei YL, Höing B, Kramer B, Lang S, Ferris RL, Kansy BA. [Stimulatory and inhibitory signaling pathways of the T cell-APC interaction and the effect of TLR agonists on APCs]. Hno. PMID 33128107 DOI: 10.1007/s00106-020-00960-8   
2020 Jost C, Darowski D, Challier J, Pulko V, Hanisch LJ, Xu W, Mössner E, Bujotzek A, Klostermann S, Umana P, Kontermann RE, Klein C. CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins. Mabs. 12: 1840709. PMID 33136521 DOI: 10.1080/19420862.2020.1840709   
2020 Lombardi A, Concepcion E, Hou H, Arib H, Mezei M, Osman R, Tomer Y. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes. Journal of Autoimmunity. 102543. PMID 32951964 DOI: 10.1016/j.jaut.2020.102543   
2020 Zhang B, Wang Y, Yuan Y, Sun J, Liu L, Huang D, Hu J, Wang M, Li S, Song W, Chen H, Zhou D, Zhang X. In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells. Annals of the Rheumatic Diseases. PMID 32998865 DOI: 10.1136/annrheumdis-2020-217844   
2020 Zhang B, Wang Y, Yuan Y, Sun J, Liu L, Huang D, Hu J, Wang M, Li S, Song W, Chen H, Zhou D, Zhang X. In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells. Annals of the Rheumatic Diseases. PMID 32998865 DOI: 10.1136/annrheumdis-2020-217844   
2020 Ecsedi M, McAfee MS, Chapuis AG. The Anticancer Potential of T Cell Receptor-Engineered T Cells. Trends in Cancer. PMID 32988787 DOI: 10.1016/j.trecan.2020.09.002   
2020 Mo Y, Cheung AKL, Liu Y, Liu L, Chen Z. Δ42PD1-TLR4 Augments γδ-T Cell Activation of the Transitional Memory Subset of CD4 T Cells. Iscience. 23: 101620. PMID 33089108 DOI: 10.1016/j.isci.2020.101620   
2020 Bozic M, Wilkinson S. Selective Autophagy Conceals the Enemy: Why Cytotoxic T Cells Don't (MH)C Pancreatic Cancer. Molecular Cell. 79: 6-8. PMID 32619471 DOI: 10.1016/j.molcel.2020.06.009   
2020 Globerson Levin A, Rawet Slobodkin M, Waks T, Horn G, Ninio-Many L, Deshet Unger N, Ohayon Y, Suliman S, Cohen Y, Tartakovsky B, Naparstek E, Avivi I, Eshhar Z. Treatment of Multiple Myeloma using Chimeric Antigen Receptor T Cells with Dual Specificity. Cancer Immunology Research. PMID 33008840 DOI: 10.1158/2326-6066.CIR-20-0118   
2020 Baharom F, Ramirez-Valdez RA, Tobin KKS, Yamane H, Dutertre CA, Khalilnezhad A, Reynoso GV, Coble VL, Lynn GM, Mulè MP, Martins AJ, Finnigan JP, Zhang XM, Hamerman JA, Bhardwaj N, et al. Intravenous nanoparticle vaccination generates stem-like TCF1 neoantigen-specific CD8 T cells. Nature Immunology. PMID 33139915 DOI: 10.1038/s41590-020-00810-3   
2020 Koh CC, Wardini AB, Vieira M, Passos LSA, Martinelli PM, Neves EGA, Antonelli LRDV, Barbosa DF, Velikkakam T, Gutseit E, Menezes GB, Giunchetti RC, Machado PRL, Carvalho EM, Gollob KJ, et al. Human CD8+ T Cells Release Extracellular Traps Co-Localized With Cytotoxic Vesicles That Are Associated With Lesion Progression and Severity in Human Leishmaniasis. Frontiers in Immunology. 11: 594581. PMID 33117407 DOI: 10.3389/fimmu.2020.594581   
2020 Darling R, Senapati S, Christiansen J, Liu L, Ramer-Tait AE, Narasimhan B, Wannemuehler M. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8 T Cell Memory and Delayed Tumor Progression. International Journal of Nanomedicine. 15: 6579-6592. PMID 32982219 DOI: 10.2147/IJN.S261041   
2020 Stary V, Pandey RV, Strobl J, Kleissl L, Starlinger P, Pereyra D, Weninger W, Fischer GF, Bock C, Farlik M, Stary G. A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses. Science Immunology. 5. PMID 33067380 DOI: 10.1126/sciimmunol.aba6232   
2020 Kiuchi T, Tomaru U, Ishizu A, Imagawa M, Iwasaki S, Suzuki A, Otsuka N, Ohhara Y, Kinoshita I, Matsuno Y, Dosaka-Akita H, Kasahara M. Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas. Journal of Clinical Pathology. PMID 32943490 DOI: 10.1136/jclinpath-2020-206618   
2020 Williams JB, Kupper TS. Resident Memory T Cells in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1273: 39-68. PMID 33119875 DOI: 10.1007/978-3-030-49270-0_3   
2020 He Y, Agnihotri P, Rangarajan S, Chen Y, Kerzic MC, Ma B, Nussinov R, Mariuzza RA, Orban J. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs). Journal of Molecular Biology. PMID 33157083 DOI: 10.1016/j.jmb.2020.10.031   
2020 Guo N, Wen Y, Wang C, Kang L, Wang X, Liu X, Soulika AM, Liu B, Zhao M, Han X, Lv P, Xing L, Zhang X, Shen H. Lung adenocarcinoma-related TNF-α-dependent inflammation upregulates MHC-II on alveolar type II cells through CXCR-2 to contribute to Treg expansion. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 34: 12197-12213. PMID 33000506 DOI: 10.1096/fj.202000166RR   
2020 Devillier R, Chrétien AS, Pagliardini T, Salem N, Blaise D, Olive D. Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy. Journal of Leukocyte Biology. PMID 32991746 DOI: 10.1002/JLB.5MR0920-198RR   
2020 Preece R, Pavesi A, Gkazi SA, Stegmann KA, Georgiadis C, Tan ZM, Aw JYJ, Maini MK, Bertoletti A, Qasim W. CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity. Molecular Therapy. Methods & Clinical Development. 19: 149-161. PMID 33102612 DOI: 10.1016/j.omtm.2020.09.002   
2020 Jardim DL, Goodman A, de Melo Gagliato D, Kurzrock R. The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. Cancer Cell. PMID 33125859 DOI: 10.1016/j.ccell.2020.10.001   
2020 Pérez-Peinado C, Valle J, Freire JM, Andreu D. Tumor Cell Attack by Crotalicidin (Ctn) and Its Fragment Ctn[15-34]: Insights into Their Dual Membranolytic and Intracellular Targeting Mechanism. Acs Chemical Biology. PMID 33021779 DOI: 10.1021/acschembio.0c00596   
2020 Choi Y, Shi Y, Haymaker CL, Naing A, Ciliberto G, Hajjar J. T-cell agonists in cancer immunotherapy. Journal For Immunotherapy of Cancer. 8. PMID 33020242 DOI: 10.1136/jitc-2020-000966   
2020 Raileanu M, Popescu A, Bacalum M. Antimicrobial Peptides as New Combination Agents in Cancer Therapeutics: A Promising Protocol against HT-29 Tumoral Spheroids. International Journal of Molecular Sciences. 21. PMID 32971958 DOI: 10.3390/ijms21186964   
2020 Jamali A, Hadjati J, Madjd Z, Mirzaei HR, Thalheimer FB, Agarwal S, Bonig H, Ullrich E, Hartmann J. Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4. Frontiers in Immunology. 11: 2028. PMID 32983147 DOI: 10.3389/fimmu.2020.02028